Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00070
|
|||||
| EM Name |
Ornithine
|
|||||
| Synonyms |
L-ornithine; ornithine; (S)-2,5-Diaminopentanoic acid; (S)-Ornithine; (S)-2,5-diaminovaleric acid; Ornithine [INN]; L-Norvaline, 5-amino-; Ornitina [Spanish]; (S)-alpha,delta-Diaminovaleric acid; Ornithinum [Latin]; polyornithine; (2S)-2,5-diaminopentanoic acid; (S)-2,5-Diaminopentanoate; Poly-L-ornithine; Ornithine (VAN); L( )-Ornithine; Pentanoic acid, 2,5-diamino-, (S)-; L-Ornithine, homopolymer; ORNITHINE, L-; UNII-E524N2IXA3; L-(-)-Ornithine; BRN 1722298; (+)-S-Ornithine; C5H12N2O2; EINECS 200-731-7; E524N2IXA3
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6262"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H12N2O2
|
|||||
| Canonical SMILES |
C(CC(C(=O)O)N)CN
|
|||||
| InChI |
InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1
|
|||||
| InChIKey |
AHLPHDHHMVZTML-BYPYZUCNSA-N
|
|||||
| CAS Number |
CAS 70-26-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 132.16 | Topological Polar Surface Area | 89.3 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-4.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:15729
|
|||||
| DT(s) "handling" This EM | GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [1] | ||
| References | ||||||
| 1 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.